Fig. 1 · Structure
Documents & Downloads
PNI 132
Ionizable Lipid
PNI 132 is an ionizable lipid designed for the formulation of lipid nanoparticles. It facilitates the encapsulation and delivery of nucleotides and therapeutic agents, enhancing their stability and bioavailability. PNI 132 is particularly useful in mRNA delivery and gene therapy applications, supporting advancements in targeted therapeutics and vaccine development.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 2568616-81-7 |
| Applications | Ionizable Lipid |
| Formula | C58H101NO6 |
| Molecular Weight | 908.43 |
| SMILES | CC/C=C\CC1C(CCC1CC(OCC(OCCCCCCCC/C=C\C/C=C\CCCCC)COCCCCCCCC/C=C\C/C=C\CCCCC)=O)OC(C2CCN(CC2)C)=O |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.